Cargando…

EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner

Glioblastoma (GBM)-derived tumorigenic stem-like cells (GSCs) may play a key role in therapy resistance. Previously, we reported that the mitotic kinase MELK binds and phosphorylates the oncogenic transcription factor FOXM1 in GSCs. Here, we demonstrate that the catalytic subunit of Polycomb repress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung-Hak, Joshi, Kaushal, Ezhilarasan, Ravesanker, Myers, Toshia R., Siu, Jason, Gu, Chunyu, Nakano-Okuno, Mariko, Taylor, David, Minata, Mutsuko, Sulman, Erik P., Lee, Jeongwu, Bhat, Krishna P.L., Salcini, Anna Elisabetta, Nakano, Ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325196/ https://www.ncbi.nlm.nih.gov/pubmed/25601206 http://dx.doi.org/10.1016/j.stemcr.2014.12.006

Ejemplares similares

Multi-Kinase Inhibitor C1 Triggers Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition
por: Minata, Mutsuko, et al.
Publicado: (2014)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

MELK—a conserved kinase: functions, signaling, cancer, and controversy
por: Ganguly, Ranjit, et al.
Publicado: (2015)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
por: Zhang, Xu, et al.
Publicado: (2021)

JMJD-1.2 controls multiple histone post-translational modifications in germ cells and protects the genome from replication stress
por: Myers, Toshia R., et al.
Publicado: (2018)

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
por: Zhang, Xu, et al.
Publicado: (2022)

Drug free remission after steroid-dependent disappearance of lymphoproliferative disorder in rheumatoid arthritis patient treated with TNF-alpha blockade: case study
por: Oda, Kosaku, et al.
Publicado: (2015)

Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype
por: Farooqi, Ahsan, et al.
Publicado: (2019)

APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death
por: Wang, Yu, et al.
Publicado: (2017)

CDK4/6 inhibition is more active against the glioblastoma proneural subtype
por: Li, Ming, et al.
Publicado: (2017)

MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2015)

Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
por: Nakano, Ichiro, et al.
Publicado: (2005)

Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
por: Beke, Lijs, et al.
Publicado: (2018)

Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
por: Cigliano, Antonio, et al.
Publicado: (2019)

Cyclosporin A inhibits prostate cancer growth through suppression of E2F8 transcription factor in a MELK‑dependent manner
por: Lee, Da Young, et al.
Publicado: (2023)

Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway
por: Meng, Fanling, et al.
Publicado: (2022)

Ethics of iPSC-Based Clinical Research for Age-Related Macular Degeneration: Patient-Centered Risk-Benefit Analysis
por: Nakano-Okuno, Mariko, et al.
Publicado: (2014)

Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2016)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

MELK is not necessary for the proliferation of basal-like breast cancer cells
por: Huang, Hai-Tsang, et al.
Publicado: (2017)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

Maslinic Acid Enhances Docetaxel Response in Human Docetaxel-Resistant Triple Negative Breast Carcinoma MDA-MB-231 Cells via Regulating MELK-FoxM1-ABCB1 Signaling Cascade
por: Wang, Ke, et al.
Publicado: (2020)

Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes
por: Sun, Hui, et al.
Publicado: (2022)

A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma
por: Boonyawan, Keeratikarn, et al.
Publicado: (2017)

DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas
por: Yang, Jie, et al.
Publicado: (2022)

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
por: Pickard, Mark R, et al.
Publicado: (2009)

MELK expression correlates with tumor mitotic activity but is not required for cancer growth
por: Giuliano, Christopher J, et al.
Publicado: (2018)

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

2193: Targeting MELK in acute lymphoblastic leukemia, new therapeutic approach
por: Alachkar, Houda, et al.
Publicado: (2018)

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
por: Laha, Dipranjan, et al.
Publicado: (2022)

Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study
por: Minata, Mutsuko, et al.
Publicado: (2022)

Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells
por: Chandran, Uma R., et al.
Publicado: (2015)

Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF(V600E) inhibition resistance in melanoma
por: Zhang, Ze-Yan, et al.
Publicado: (2022)

A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells
por: Wang, Yubao, et al.
Publicado: (2018)

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
por: Chen, Hengyu, et al.
Publicado: (2022)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
por: Wang, Yubao, et al.
Publicado: (2014)

MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway
por: Xu, Qinyang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pv4nb5biu1bp88rjpec3fg0af8